Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02483741
Other study ID # UDDS-OMFS-04-2015
Secondary ID
Status Completed
Phase N/A
First received June 25, 2015
Last updated December 5, 2016
Start date June 2015
Est. completion date November 2016

Study information

Verified date December 2016
Source Damascus University
Contact n/a
Is FDA regulated No
Health authority Syria: Ministry of Higher Education
Study type Interventional

Clinical Trial Summary

Since there is an evidence that Manuka honey is an antibacterial agent, the present study aims to confirm this characteristic and assess its effect in improving healing and reducing postsurgical symptoms, if topically applied after the surgical removal of impacted mandibular third molars


Description:

Sufficient evidence exists recommending the use of honey in the management of acute wounds and burns. Studies revealed that the healing effect of honey could be classified by its antibacterial, antiviral, anti-inflammatory and antioxidant properties of its components. Manuka honey has been shown to inhibit a wide range of microorganisms, including multiresistant strains. This unique honey is derived from flowers of manuka tree (Leptospermum scoparium) in New Zealand. Dihydroxyacetone and methylglyoxal are unique and naturally occurring constituents of manuka honey that correlate with its antibacterial activity.

Since surgical extraction of impacted molars is one of the most common operations in the oral cavity and the postoperative symptoms disturbing the patient may reduce the quality of health service, this study aims to assess the healing potential of Manuka honey in reducing these symptoms by comparing the outcome of extraction of impacted lower molars with and without topical application of Manuka honey into the extraction socket.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date November 2016
Est. primary completion date May 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years to 37 Years
Eligibility Inclusion Criteria:

- Asymptomatic, Symmetrical, Bilateral Impacted Third Molars

Exclusion Criteria:

- Uncontrolled diabetes,

- Hypersensitivity to Honey

- Alcoholism,

- Drug abuse,

- Pathological condition in the region

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Biological:
Manuka Honey
This material is going to be placed into the sockets of the extracted third molars in the experimental group

Locations

Country Name City State
Syrian Arab Republic Department of Oral and Maxillofacial Surgery, University of Damascus Dental School Damascus Damscus

Sponsors (1)

Lead Sponsor Collaborator
Damascus University

Country where clinical trial is conducted

Syrian Arab Republic, 

References & Publications (7)

Atrott J, Haberlau S, Henle T. Studies on the formation of methylglyoxal from dihydroxyacetone in Manuka (Leptospermum scoparium) honey. Carbohydr Res. 2012 Nov 1;361:7-11. doi: 10.1016/j.carres.2012.07.025. — View Citation

Mavric E, Wittmann S, Barth G, Henle T. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res. 2008 Apr;52(4):483-9. doi: 10.1002/mnfr.200700282. — View Citation

Rathnam A, Madan N, Madan N. The language of pain: A short study. Contemp Clin Dent. 2010 Jul;1(3):142-5. doi: 10.4103/0976-237X.72778. — View Citation

Ruta DA, Bissias E, Ogston S, Ogden GR. Assessing health outcomes after extraction of third molars: the postoperative symptom severity (PoSSe) scale. Br J Oral Maxillofac Surg. 2000 Oct;38(5):480-7. — View Citation

Singh V, Pal US, Singh R, Soni N. Honey a sweet approach to alveolar osteitis: A study. Natl J Maxillofac Surg. 2014 Jan;5(1):31-4. doi: 10.4103/0975-5950.140166. — View Citation

Wijesinghe M, Weatherall M, Perrin K, Beasley R. Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. N Z Med J. 2009 May 22;122(1295):47-60. Review. — View Citation

Yaghoobi R, Kazerouni A, Kazerouni O. Evidence for Clinical Use of Honey in Wound Healing as an Anti-bacterial, Anti-inflammatory Anti-oxidant and Anti-viral Agent: A Review. Jundishapur J Nat Pharm Prod. 2013 Aug;8(3):100-4. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Levels of postoperative discomfort Postoperative Symptom Severity (PoSSe) Scale will be used for this variable. The patient will be asked to fill in a questionnaire on the 7th day following surgery. This questionnaire is used to assess postoperative discomfort in patients who have third molars extracted. PoSSe Scale consists of 7 sub-scales that investigate the patient's ability to enjoy food; speak properly; perceive altered sensations, appearance, pain, and sickness; and interference with daily activities. 7 days after the surgical removal of third molars No
Primary Change of facial contours due to swelling In order to assess facial swelling, the distances between the labial commissure and the tragus, and between the lateral canthus and the gonion will be measured.
The change between 3 days and before surgery will give an idea about the amount of swelling that occurred following surgery.
Between 3 days and 7 days will give an idea about the change that occurred in this period.
Measurements will be taken before surgery, on the 3rd and on the 7th days after surgery. No
Primary Change of the masticatory muscles status Mouth opening range will be assessed by measuring the distance between the upper and lower incisors using a vernier caliper when the patient is asked to open his/her mouth as much as possible.
The presence of limited opening of the mouth is an indication of trismus.
Measurements will be taken before surgery, on the 3rd and on the 7th days after surgery. No
Primary Pain and Change of pain using a Visual Analog Scale of Faces (VASoF). This will be assessed on the 3rd and 7th day following surgery No
Primary The presence or absence of alveolar osteitis The presence of a dry socket condition will be checked out at two time points. This will be assessed on the 3rd and 7th day following surgery No
Secondary Time required to hemostasis This will be recorded by the patient in the immediate postsurgical phase (i.e. between 10 minutes up to 72 hours following surgery) No
Secondary Bone density and quality This will be assessed using Cone-beam computed tomography (CBCT) images. Hounsfield Units will be used to quantify bone density and quality. at six months following surgery No
Secondary Change of bone healing status This will be assessed using panoramic radiographs at 3 and six months following surgery No